Individualization of dose and fractionation of radiotherapy for head and neck cancers

P. Blanchard; J. Biau; J. Castelli; Y. Tao; P. Graff; F. Nguyen

doi:10.1016/j.canrad.2019.07.131

Individualization of dose and fractionation of radiotherapy for head and neck cancers

P. Blanchard, J. Biau, J. Castelli, Y. Tao, P. Graff, F. Nguyen

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed.

Translated title of the contribution	Personnalisation de la dose et du fractionnement de la radiothérapie des cancers de la tête et du cou
Original language	English
Pages (from-to)	784-788
Number of pages	5
Journal	Cancer/Radiotherapie
Volume	23
Issue number	6-7
DOIs	https://doi.org/10.1016/j.canrad.2019.07.131
Publication status	Published - 1 Oct 2019

Keywords

Chemotherapy
Epstein–Barr virus
Fractionation
Head and neck cancer
Meta-analysis
Nasopharyngeal cancer
Radiotherapy

Access to Document

10.1016/j.canrad.2019.07.131

Cite this

@article{b571334bc16741c28843ae4789f6ad0a,

title = "Individualization of dose and fractionation of radiotherapy for head and neck cancers",

abstract = "Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed.",

keywords = "Chemotherapy, Epstein–Barr virus, Fractionation, Head and neck cancer, Meta-analysis, Nasopharyngeal cancer, Radiotherapy",

author = "P. Blanchard and J. Biau and J. Castelli and Y. Tao and P. Graff and F. Nguyen",

note = "Publisher Copyright: {\textcopyright} 2019 Soci{\'e}t{\'e} fran{\c c}aise de radioth{\'e}rapie oncologique (SFRO)",

year = "2019",

month = oct,

day = "1",

doi = "10.1016/j.canrad.2019.07.131",

language = "English",

volume = "23",

pages = "784--788",

journal = "Cancer/Radiotherapie",

issn = "1278-3218",

number = "6-7",

}

TY - JOUR

T1 - Individualization of dose and fractionation of radiotherapy for head and neck cancers

AU - Blanchard, P.

AU - Biau, J.

AU - Castelli, J.

AU - Tao, Y.

AU - Graff, P.

AU - Nguyen, F.

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed.

AB - Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed.

KW - Chemotherapy

KW - Epstein–Barr virus

KW - Fractionation

KW - Head and neck cancer

KW - Meta-analysis

KW - Nasopharyngeal cancer

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85072545764&partnerID=8YFLogxK

U2 - 10.1016/j.canrad.2019.07.131

DO - 10.1016/j.canrad.2019.07.131

M3 - Article

C2 - 31420129

AN - SCOPUS:85072545764

SN - 1278-3218

VL - 23

SP - 784

EP - 788

JO - Cancer/Radiotherapie

JF - Cancer/Radiotherapie

IS - 6-7

ER -

Individualization of dose and fractionation of radiotherapy for head and neck cancers

Abstract

Keywords

Access to Document

Other files and links

Cite this